UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000017885
Receipt No. R000020383
Official scientific title of the study Relationship between ambulatory blood pressure monitoring and renal tissue injury
Date of disclosure of the study information 2015/06/12
Last modified on 2016/06/09 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Relationship between ambulatory blood pressure monitoring and renal tissue injury
Title of the study (Brief title) ABPM and renal tissue damage
Region
Japan

Condition
Condition glomerulonephritis
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Hypertension is a common complication in chronic kidney disease patients. However, the influence of patterns of HT on renal tissue damage remains unclear.
Basic objectives2 Others
Basic objectives -Others We investigate the relationship between ambulatory blood pressure monitoring and renal tissue injury in glomerulonephritis.
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Renal tissue damage(glomerulosclerosis, interstitial fibrosis, intminal thickening of intra-lobular arteries, artriolar hyalinosis)
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria over 16 years old
patients with 24hr ABPM
Key exclusion criteria patients who reject joining this study
Target sample size 100

Research contact person
Name of lead principal investigator Nishi Shinichi
Organization Kobe University Graduate School of Medicine
Division name Division of Nephrology
Address Kusunoki-cho 7-5-2, Chuou-ku, Kobe city
TEL 078-382-6500
Email snishi@med.kobe-u.ac.jp

Public contact
Name of contact person Kono Keiji
Organization Kobe University Graduate School of Medicine
Division name Division of Nephrology
Address Kusunoki-cho 7-5-2, Chuou-ku, Kobe city
TEL 078-382-6500
Homepage URL
Email kkono@med.kobe-u.ac.jp

Sponsor
Institute Kobe university graduate school of medicine
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Kobe university graduate school of medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 神戸大学病院、明石医療センター

Other administrative information
Date of disclosure of the study information
2015 Year 06 Month 12 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 06 Month 12 Day
Anticipated trial start date
2015 Year 06 Month 12 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information Retrospective observational study

Management information
Registered date
2015 Year 06 Month 12 Day
Last modified on
2016 Year 06 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020383